HEMOGENYX PHARMACEUTICALS PLC (HEMO) — research page
UK · uk-cm-kg/LSE/HEMO · as of 2026-11-06
Identity and listing
HEMOGENYX PHARMACEUTICALS PLC is listed on the LSE Main Market under ticker HEMO, ISIN GB00BQVXM815 and LEI 2138008L93GYU5GN6179. Its security type is Corporate and its segment is SET3. Its sector is Pharmaceuticals and Biotechnology [201030], and its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | HEMOGENYX PHARMACEUTICALS PLC | source · 2026-11-06 |
| exchange | LSE Main Market | source · 2026-11-06 |
| ticker | HEMO | source · 2026-11-06 |
| ISIN | GB00BQVXM815 | source · 2026-11-06 |
| LEI | 2138008L93GYU5GN6179 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | SET3 | source · 2026-11-06 |
| sector | Pharmaceuticals and Biotechnology [201030] | source · 2026-11-06 |
| jurisdiction | England and Wales (Companies House jurisdiction field) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 31 filings on 28 filing days in the window 2025-11-06 to 2026-11-06. The median gap between filing days is 10 days, against a median of 4 days for the LSE Main Market and 6.0 days for the sector. Days from the latest filing to the record date are 57, against a median of 3 days for the exchange and 4.0 days for the sector. The latest filing is a ch_capital filing dated 2026-09-10. The exchange median filing count is 29.0 and the sector median is 42 filings.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 31 | 10 | 57 |
| exchange median: LSE Main Market (892 issuers) | 29 | 4 | 3 |
| sector median: Pharmaceuticals and Biotechnology [201030] (51 issuers) | 42 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-09-10 | ch_capital | capital allotment shares — 2026-09-08 | |
| 2026-09-03 | corporate_action | Exercise of Warrants and Issue of Equity | |
| 2026-08-11 | regulatory_announcement | Collaboration with Cellin Technologies | |
| 2026-07-29 | regulatory_announcement | Collaboration and Company Update | |
| 2026-07-14 | ch_resolution | resolution |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is PKF Littlejohn LLP. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is not set: the issuer is listed, not halted.
Orderability
For the elective professional client category the outcome is signal ACM-200, determinable. For the eligible counterparty category the outcome is signal ACM-200, determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| elective professional client | ACM-200 |
| eligible counterparty | ACM-200 |
rule acm-68000/uk/product-governance-fca-prod-sourcebook/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations page. The count is 0.
Open research
No openly published research notes were found. The count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No issuer years are sealed. The live record began on 2026-09-11. Years 2021 to 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.
Sources
10 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)
- 10.2
- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/HEMO (identity.isin)
- 10.3
- https://find-and-update.company-information.service.gov.uk/company/08401609 (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://www.londonstockexchange.com/stock/HEMO/hemogenyx-pharmaceuticals-plc/company-page (identity.sector)
- 10.6
- https://mcp.uk-cm-kg.ai/events/LSE/HEMO (the disclosure lines)
- 10.7
- https://marketsecurities.fca.org.uk/officiallist (the halt flag)
- 10.8
- https://hemogenyx.com/wp-content/uploads/2023/06/2138008L93GYU5GN6179-2022-12-31-en.html (the auditor)
- 10.9
- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.10
- https://mcp.uk-cm-kg.ai/record/LSE/HEMO (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"GB00BQVXM815"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:f644fc53e9758ebb.